Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1

Doxorubicin (DOX) leads to myocardial cell damage and irreversible heart failure, which limits the clinical application of DOX. Naringin has biological functions of inhibiting inflammation, oxidative stress and apoptosis. Our aim was to investigate whether Naringin could prevent DOX-related cardioto...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zirui, Yang, Shilei, Deng, Yawen, Wang, Liang, Zhang, Yifen, Feng, Zhenyu, Li, Han, Chi, Zhongchao, Xie, Yunpeng, Dong, Deshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039159/
https://www.ncbi.nlm.nih.gov/pubmed/35496302
http://dx.doi.org/10.3389/fphar.2022.859755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039159/
https://www.ncbi.nlm.nih.gov/pubmed/35496302
http://dx.doi.org/10.3389/fphar.2022.859755

Ejemplares similares